CL2003002385A1 - Tableta farmaceutica que comprende 0,1 a 10% de tibolona provista con un revestimiento. - Google Patents

Tableta farmaceutica que comprende 0,1 a 10% de tibolona provista con un revestimiento.

Info

Publication number
CL2003002385A1
CL2003002385A1 CL200302385A CL2003002385A CL2003002385A1 CL 2003002385 A1 CL2003002385 A1 CL 2003002385A1 CL 200302385 A CL200302385 A CL 200302385A CL 2003002385 A CL2003002385 A CL 2003002385A CL 2003002385 A1 CL2003002385 A1 CL 2003002385A1
Authority
CL
Chile
Prior art keywords
tibolone
coating
pharmaceutical tablet
tablet
pharmaceutical
Prior art date
Application number
CL200302385A
Other languages
English (en)
Inventor
Haan Pieter Van Lare C E J De
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of CL2003002385A1 publication Critical patent/CL2003002385A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
CL200302385A 2002-11-20 2003-11-18 Tableta farmaceutica que comprende 0,1 a 10% de tibolona provista con un revestimiento. CL2003002385A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42774002P 2002-11-20 2002-11-20
EP02079920 2002-11-20

Publications (1)

Publication Number Publication Date
CL2003002385A1 true CL2003002385A1 (es) 2005-01-14

Family

ID=32327854

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200302385A CL2003002385A1 (es) 2002-11-20 2003-11-18 Tableta farmaceutica que comprende 0,1 a 10% de tibolona provista con un revestimiento.

Country Status (11)

Country Link
US (1) US20060051420A1 (es)
KR (1) KR20050085024A (es)
AR (1) AR042083A1 (es)
CL (1) CL2003002385A1 (es)
CO (1) CO5590891A2 (es)
EC (1) ECSP055811A (es)
HR (1) HRP20050430A2 (es)
IS (1) IS7821A (es)
LV (1) LV13346B (es)
NO (1) NO20052305L (es)
PE (1) PE20040839A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2602730T3 (es) * 2003-09-24 2017-02-22 Novartis Consumer Health S.A. Comprimidos de diclofenaco revestidos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751277A (en) * 1971-03-24 1973-08-07 Dow Chemical Co Tablet coating process and composition
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
CA2164344C (en) * 1993-08-30 2004-06-29 Stanley Lech Tablet coating based on a melt-spun mixture of a saccharide and a polymer

Also Published As

Publication number Publication date
US20060051420A1 (en) 2006-03-09
CO5590891A2 (es) 2005-12-30
NO20052305L (no) 2005-06-07
PE20040839A1 (es) 2004-11-17
LV13346B (en) 2005-12-20
KR20050085024A (ko) 2005-08-29
ECSP055811A (es) 2005-08-11
HRP20050430A2 (en) 2005-06-30
AR042083A1 (es) 2005-06-08
IS7821A (is) 2005-04-25

Similar Documents

Publication Publication Date Title
AP2201A (en) Sustained-release tablet composition of pramipexole.
IL179432A0 (en) Pharmaceutical tablets comprising two or more unitary segments
NL1021857A1 (nl) Tamsulosinetabletten met een gewijzigde vrijgave.
MXPA05012637A (es) Tableta de liberacion modificada del clorhidrato de bupropion.
ATE380544T1 (de) Umhüllte feste darreichungsform
ID30225A (id) Tablet matriks yang memungkinkan pelepasan yang diperlama dari gliklazida setelah pemberian secara oral
IS7564A (is) Lyfjablanda með breytta losun
ATE388693T1 (de) Wohlschmeckende kautablette
ZA200410410B (en) New etonogestrel esters.
NO20041195L (no) Tablettmater.
MA27889A1 (fr) Comprime contenant de la fluvastatine et de la carmellose calcique
UY27270A1 (es) Comprimido de meloxicam de rápida disgregación
ITMI20021725A1 (it) Composizioni farmaceutiche ad attivita' antibiotica.
MXPA03009689A (es) TABLETA FARMACEUTICA QUE TIENE ALTO CONTENIDO DE INGREDIENTE FARMACeUTICO ACTIVO (IFA).
DE60209673D1 (de) Tablettenbeschichtungen
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
RU2002107079A (ru) Вещество, обладающее седативным действием
ITRM20020305A1 (it) Camptotecine con anello lattonico modificato.
CL2003002385A1 (es) Tableta farmaceutica que comprende 0,1 a 10% de tibolona provista con un revestimiento.
EA200600066A1 (ru) Тамсулозинсодержащее ядро, покрытое поливинилпирролидоном или поливинилацетатом
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
AP2005003247A0 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes.
IS7537A (is) Notkun á nýjum etónógestrel esterum.
ITMI20021745A1 (it) Procedimento per utilizzare un filatoio.
ZA200408787B (en) Pharmaceutical combination.